Michael Bettess
Président chez Currus Biologics Pty Ltd.
Profil
Michael Bettess is currently the Chairman at Currus Biologics Pty Ltd., the Director at Cincera Therapeutics Pty Ltd., and the Senior Investment Manager at Brandon Capital Partners Pty Ltd.
He previously worked as the Director at Heart Metabolics Ltd.
and as the Investment Manager at Trans Tasman Fund Management Pty Ltd.
Dr. Bettess obtained an MBA from LaTrobe University in 2008.
Postes actifs de Michael Bettess
| Sociétés | Poste | Début |
|---|---|---|
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Private Equity Investor | 01/02/2016 |
Cincera Therapeutics Pty Ltd.
 Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Cincera Therapeutics Pty Ltd. is a biotechnology company, which develops molecule drugs. It focuses on the discovery and development of new small molecule drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity and metabolic disorders, with potential applications in many other disease areas including cancer. The company was founded by Bernard Flynn and Stuart Pitson and is headquartered in Melbourne, Australia. | Directeur/Membre du Conseil | - |
Currus Biologics Pty Ltd.
 Currus Biologics Pty Ltd. BiotechnologyHealth Technology Currus Biologics Pty Ltd. is an Australian biotechnology company that develops cell therapies to treat cancers. The company is based in Melbourne, Australia. The CEO of the company is Samantha Cobb. | Président | - |
Anciens postes connus de Michael Bettess
| Sociétés | Poste | Fin |
|---|---|---|
Trans Tasman Fund Management Pty Ltd.
 Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance Trans Tasman Fund Management Pty Ltd (TTCF) is a venture capital firm headquartered in Australia. | Private Equity Investor | - |
Heart Metabolics Ltd.
 Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Directeur/Membre du Conseil | - |
Formation de Michael Bettess
| LaTrobe University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Trans Tasman Fund Management Pty Ltd.
Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance Trans Tasman Fund Management Pty Ltd (TTCF) is a venture capital firm headquartered in Australia. | Finance |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
Cincera Therapeutics Pty Ltd.
Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Cincera Therapeutics Pty Ltd. is a biotechnology company, which develops molecule drugs. It focuses on the discovery and development of new small molecule drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity and metabolic disorders, with potential applications in many other disease areas including cancer. The company was founded by Bernard Flynn and Stuart Pitson and is headquartered in Melbourne, Australia. | Commercial Services |
Currus Biologics Pty Ltd.
Currus Biologics Pty Ltd. BiotechnologyHealth Technology Currus Biologics Pty Ltd. is an Australian biotechnology company that develops cell therapies to treat cancers. The company is based in Melbourne, Australia. The CEO of the company is Samantha Cobb. | Health Technology |
